Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer Stage|Insulin Resistance|Racial Bias
Interventions: DRUG: Metformin Extended Release Oral Tablet
Sponsor: Woman's
Collaborators: Our Lady of the Lake Hospital|American Cancer Society, Inc.|Pfizer